News
Lilly's valuation seems reasonable given its growth prospects. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY ...
Key Points Revenue (GAAP) climbed 73% year over year in the second quarter of 2025 but missed consensus estimates by 1.2%. Net income (GAAP) and Adjusted EBITDA more than doubled, while gross margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback